Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRDL Cardiol Therapeutics	$1.34 +20.7%	$1.34	$0.77 ▼ $2.63	$91.77M	1.05	979,918 shs	3.53 million shs
CXF CI Canadian Convertible Bond ETF Common	C$10.34 -0.3%	C$10.28	C$9.72 ▼ C$10.57	C$52.27M	N/A	4,246 shs	1,001 shs
IPA ImmunoPrecise Antibodies	$2.02 +1.5%	$1.47	$0.27 ▼ $2.41	$91.85M	0.49	1.35 million shs	450,871 shs
ITH International Tower Hill Mines	C$1.72 -5.5%	C$1.43	C$0.59 ▼ C$2.04	C$241.48M	1.17	31,186 shs	3,217 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRDL Cardiol Therapeutics	+20.18%	+24.07%	+3.88%	+20.72%	-32.66%
CXF CI Canadian Convertible Bond ETF Common	-0.29%	-0.29%	+1.37%	+3.30%	+4.66%
IPA ImmunoPrecise Antibodies	+1.51%	+9.19%	+10.99%	+308.25%	+197.06%
ITH International Tower Hill Mines	-5.49%	-12.24%	+17.01%	+86.96%	+186.67%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRDL Cardiol Therapeutics	2.5331 of 5 stars	3.7	2.0	0.0	0.0	3.8	0.0	0.6
CXF CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	2.2809 of 5 stars	3.5	3.0	0.0	0.0	2.5	0.0	0.6
ITH International Tower Hill Mines	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRDL Cardiol Therapeutics	3.33	Buy	$8.00	497.01% Upside
CXF CI Canadian Convertible Bond ETF Common	0.00	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	3.00	Buy	$4.00	98.02% Upside
ITH International Tower Hill Mines	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CXF, IPA, ITH, and CRDL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
6/2/2025	CRDL Cardiol Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	$0.22 per share	N/A
CXF CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	$17.59M	5.30	N/A	N/A	$0.37 per share	5.46
ITH International Tower Hill Mines	N/A	N/A	C$0.08 per share	22.50	C$0.29 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRDL Cardiol Therapeutics	-$26.77M	-$0.34	N/A	N/A	N/A	N/A	-209.63%	-141.09%	N/A
CXF CI Canadian Convertible Bond ETF Common	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	-$21.69M	-$0.68	N/A	N/A	N/A	-122.10%	-40.62%	-22.19%	9/15/2025 (Estimated)
ITH International Tower Hill Mines	-C$2.36M	-C$0.02	N/A	∞	N/A	N/A	-5.82%	-3.65%	N/A

Latest CXF, IPA, ITH, and CRDL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/11/2025	Q2 2025	CRDL Cardiol Therapeutics	-$0.11	-$0.07	+$0.04	-$0.07	N/A	N/A
7/29/2025	Q4 2025	IPA ImmunoPrecise Antibodies	-$0.02	-$0.04	-$0.02	-$0.04	$7.89 million	$5.06 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	N/A
CXF CI Canadian Convertible Bond ETF Common	C$0.48	4.64%	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	N/A	N/A	N/A	N/A	N/A
ITH International Tower Hill Mines	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRDL Cardiol Therapeutics	0.01	3.26	3.26
CXF CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A
IPA ImmunoPrecise Antibodies	0.49	2.08	1.85
ITH International Tower Hill Mines	N/A	10.37	30.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRDL Cardiol Therapeutics	12.49%
CXF CI Canadian Convertible Bond ETF Common	N/A
IPA ImmunoPrecise Antibodies	6.70%
ITH International Tower Hill Mines	71.80%

Insider Ownership

Company	Insider Ownership
CRDL Cardiol Therapeutics	5.25%
CXF CI Canadian Convertible Bond ETF Common	N/A
IPA ImmunoPrecise Antibodies	6.83%
ITH International Tower Hill Mines	0.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRDL Cardiol Therapeutics	20	82.68 million	78.34 million	Not Optionable
CXF CI Canadian Convertible Bond ETF Common	90	5.05 million	N/A	Not Optionable
IPA ImmunoPrecise Antibodies	80	46.15 million	43.00 million	Not Optionable
ITH International Tower Hill Mines	220	140.40 million	N/A	Not Optionable

CXF, IPA, ITH, and CRDL Headlines

Recent News About These Companies

International Tower Hill Mines (TSE:ITH) Hits New 12-Month High - What's Next?

August 6, 2025 | marketbeat.com

International Tower Hill Mines (TSE:ITH) Trading Down 6.6% - What's Next?

August 1, 2025 | marketbeat.com

International Tower Hill Mines (TSE:ITH) Hits New 12-Month High - Here's Why

July 31, 2025 | marketbeat.com

International Tower Hill Mines (TSE:ITH) Reaches New 1-Year High - Time to Buy?

July 24, 2025 | marketbeat.com

International Tower Hill Mines: Akin To NovaGold's Little Brother

July 15, 2025 | seekingalpha.com

International Tower Hill Mines Ltd. (THM) - Yahoo Finance

June 27, 2025 | nz.finance.yahoo.com

International Tower Hill Mines Files 2025 First Quarter Financial Results

May 9, 2025 | finance.yahoo.com

International Tower Hill Mines Ltd. (THM): Among Billionaire John Paulson’s Stocks with Huge Upside Potential

May 7, 2025 | uk.finance.yahoo.com

Trump signs order seeking to jump-start mining of the ocean floor

April 25, 2025 | msn.com

International mining giant dropping out of partnership in Alaska gold mining project

April 24, 2025 | alaskabeacon.comA

Why International Tower Hill Mines Ltd.’s (THM) Stock Is Up 8.29%

April 11, 2025 | aaii.comA

International Tower Hill Mines Approves 2025 Livengood Gold Project Work Plan and Files 2024 Year End Financial Results

March 12, 2025 | ca.finance.yahoo.com

International Tower Hill Mines announces $3.9M non-brokered private placement

March 4, 2025 | markets.businessinsider.com

7 Most Obscure Towns In America You Wouldn't Think To Visit

November 7, 2024 | msn.com

Hedge funds investors control 32% of International Tower Hill Mines Ltd. (TSE:ITH) and were rewarded last week after stock increased 44%

October 17, 2024 | finance.yahoo.com

Just Over the Border from Israel, a Hezbollah Cache of Explosives and Mines

October 14, 2024 | nytimes.com

Prince Harry Is Keeping Princess Diana's Landmine Legacy Alive: 'He Wants to Finish the Job' (Exclusive)

September 29, 2024 | people.comP

Dozens of Massachusetts lawmakers tell RMV to hit the brakes on revoking CDLs

September 27, 2024 | ca.news.yahoo.com

After personal appeal from Zelensky, Trump agrees to meet with the Ukrainian president after all

September 27, 2024 | washingtonexaminer.comW

8 Theme Parks That Go All Out for Halloween and Christmas

September 25, 2024 | msn.com

Election 2024 live updates: Trump returns to N.C.; Harris delivering economic address in Pa.

September 25, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CXF, IPA, ITH, and CRDL Company Descriptions

Cardiol Therapeutics NASDAQ:CRDL

$1.34 +0.23 (+20.72%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$1.34 +0.00 (+0.37%)

As of 08/14/2025 07:58 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

CI Canadian Convertible Bond ETF Common TSE:CXF

C$10.34 -0.03 (-0.29%)

As of 08/14/2025 10:20 AM Eastern

The investment objectives of First Asset Canadian Convertible Bond ETF are to provide holders with (i) quarterly cash distributions, and (ii) the opportunity for capital appreciation by investing on a capitalization weighted basis in a portfolio (the Convertible Portfolio) of Convertible Bonds of Canadian issuers. The Convertible ETF will invest on a capitalization weighted basis in Convertible Bonds which meet the Eligibility Criteria. Capitalization weightings are determined on the basis of a Convertible Bonds relative market capitalization to the total market capitalization of Convertible Bonds included in the Convertible Portfolio, on initial investment and on quarterly rebalancings.

ImmunoPrecise Antibodies NASDAQ:IPA

$2.02 +0.03 (+1.51%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$1.98 -0.04 (-1.98%)

As of 08/14/2025 07:46 PM Eastern

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes. Additionally, the company offers LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; and antibody chimerization for cloning and production of variable antibody domain. It also provides Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom technologies and applications; and breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts. The company was incorporated in 1983 and is headquartered in Victoria, Canada.

International Tower Hill Mines TSE:ITH

C$1.72 -0.10 (-5.49%)

As of 08/14/2025 03:59 PM Eastern

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an advanced stage exploration project namely the Livengood Gold Project. It is located approximately 70 miles northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska mental health trust, a number of smaller private mineral leases, Alaska state mining claims purchased or located by the company and patented ground held by the company.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time